secwatch.observer — SEC 8-K summary
======================================

Issuer:     Picard Medical, Inc. (PMI)
CIK:        0002030617
Form:       8-K
Filed at:   2026-03-25T23:59:59+00:00
Accession:  0001829126-26-002663
Event type: earnings
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Picard Medical FY2025 revenue up 12.5% to $4.9M, net loss widens to $27.0M
--------------------------------------------------------------------------

- Revenue $4.94M (+12.5% YoY); product revenue $4.75M, 96% of total.
- Gross margin negative 4.1% vs -2.6% in 2024; gross loss $(0.2)M.
- Operating loss $(13.3)M, slightly improved from $(13.7)M; net loss $(27.0)M vs $(21.1)M.
- Cash & equivalents $11.5M at year-end vs $0.1M in 2024; raised $17.4M net from equity and $9.7M net from debt in 2025.
- Company expects to continue investing; additional capital needed to support operations.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2030617/000182912626002663/0001829126-26-002663-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2030617/000182912626002663/picardmedical_8k.htm
  HTML page:      https://secwatch.observer/filing/0001829126-26-002663

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer